Diabetes abnormal index early warning system and method based on recurrent neural network
By integrating multiple health monitoring devices and convolutional gated recurrent neural networks for comprehensive analysis, the systemic and real-time deficiencies in diabetes management in existing technologies have been addressed, enabling comprehensive monitoring and personalized early warning for diabetic patients, and improving prediction accuracy and management effectiveness.
Patent Information
- Application Number
- CN202410946833.0
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Filing Date
- 2024-07-16
- Publication Date
- 2026-01-16
AI Technical Summary
Existing technologies lack a systematic and comprehensive approach to diabetes management. Traditional blood glucose monitoring methods cannot fully reflect the patient's health status. Data from various physiological indicators monitored by smart devices exist in isolation. Machine learning algorithms suffer from insufficient accuracy and poor real-time performance when processing large-scale, multi-dimensional time-series data.
A diabetes abnormality indicator early warning system based on recurrent neural networks is adopted. It integrates multiple health monitoring devices to collect various physiological indicator data in real time, and performs comprehensive analysis through convolutional gated recurrent neural networks to generate personalized early warning information, including data acquisition, preprocessing, feature extraction and early warning generation.
It enables comprehensive monitoring and real-time early warning of diabetic patients, improves the accuracy of predicting abnormal diabetes indicators, provides personalized health management suggestions, and enhances the effectiveness of diabetes management.